Radius Health DSO Ratio 2011-2026 | RDUS

Annual DSO Ratio Radius Health

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
34.7	33.3	42.2	39	106	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
106	33.3	51

Quarterly DSO Ratio Radius Health

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	44.3	56.7	-	40.3	44	37.8	-	22.9	44	51.1	36.7	44.1	49.4	57.3	39.3	39.4	38.3	39.2	96	43.7	263	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
263	22.9	57.2

DSO Ratio of other stocks in the Drug manufacturers industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Endo International plc ENDP	79.9	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	55.1	-	-	$ 36.6 M	USA
Cumberland Pharmaceuticals CPIX	382	$ 5.64	0.71 %	$ 83.8 M	USA
HEXO Corp. HEXO	71.3	-	2.45 %	$ 38.1 M	Canada
AcelRx Pharmaceuticals ACRX	86.6	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	96.2	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	71.7	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	117	-	-	$ 754 M	USA
Agile Therapeutics AGRX	63.1	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	122	-	-	$ 142 M	USA
Cronos Group CRON	61.7	$ 2.63	-2.05 %	$ 1.01 B	Canada
Athenex ATNX	89.9	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	87.8	$ 39.44	4.78 %	$ 1.45 B	USA
Avadel Pharmaceuticals plc AVDL	49.9	-	-	$ 2.06 B	France
Catalent CTLT	80.1	-	-	$ 11.5 B	USA
Organogenesis Holdings ORGO	106	$ 2.42	3.63 %	$ 307 M	USA
Eagle Pharmaceuticals EGRX	65.5	-	-39.89 %	$ 27.7 M	USA
Pacira BioSciences PCRX	50.3	$ 23.03	0.17 %	$ 1.07 B	USA
Canopy Growth Corporation CGC	62.7	$ 0.98	-1.81 %	$ 105 M	Canada
Sonoma Pharmaceuticals SNOA	65.5	$ 1.13	3.67 %	$ 1.4 M	USA
Aurora Cannabis ACB	99.8	$ 3.05	0.33 %	$ 167 M	Canada
Jupiter Wellness JUPW	51.9	-	-	$ 33.6 M	USA
Lannett Company LCI	83.1	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	93	$ 1.04	-1.44 %	$ 99.1 M	Canada
Tilray TLRY	52.8	$ 5.05	1.41 %	$ 3.12 B	Canada
Evolus EOLS	62.9	$ 6.8	0.97 %	$ 438 M	USA
Emergent BioSolutions EBS	58.6	$ 8.33	0.12 %	$ 446 M	USA
cbdMD YCBD	13.4	$ 0.7	2.06 %	$ 2.82 M	USA
Veru VERU	91.5	$ 3.17	5.67 %	$ 46.4 M	USA
Neoleukin Therapeutics NLTX	3.46	-	-	$ 193 M	Canada
Assertio Holdings ASRT	268	$ 23.5	0.09 %	$ 150 M	USA
ProPhase Labs PRPH	907	-	-	$ 5.07 M	USA
Bausch Health Companies BHC	79.8	$ 5.06	-	$ 1.88 B	Canada
PetIQ PETQ	43.1	-	1.64 %	$ 400 M	USA
Recro Pharma REPH	62.7	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	108	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	2.74	$ 4.31	1.89 %	$ 215 M	USA
PLx Pharma PLXP	14.1	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	67	$ 16.38	-0.64 %	$ 19.1 B	USA
Zomedica Corp. ZOM	31	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	14.6 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	43.3	$ 0.65	4.27 %	$ 23.4 M	USA
China Pharma Holdings CPHI	20.9	$ 0.78	4.82 %	$ 3.35 M	China
TherapeuticsMD TXMD	2.3 K	$ 2.39	8.64 %	$ 27.6 M	USA